Century Therapeutics (IPSC) EBT Margin (2022 - 2025)

Century Therapeutics (IPSC) has 4 years of EBT Margin data on file, last reported at 70.13% in Q1 2025.

• On a quarterly basis, EBT Margin rose 335212.0% year-over-year to 70.13% in Q1 2025; TTM through Dec 2025 was 0.05%, a 189348.0% increase from a year earlier, with the FY2025 full-year figure at 0.04%, up 189374.0% from the prior year.
• EBT Margin for Q1 2025 stood at 70.13%, up from 821.88% in the prior quarter.
• Over the last five years, EBT Margin for IPSC reached as high as 70.13% in Q1 2025 and fell as low as 32667.68% in Q2 2023.
• Historically, EBT Margin has averaged 7414.95% across 4 years, with a median of 3544.14% in 2022.
• Across the five-year window, EBT Margin plunged 3044920 bps in 2023 and surged 2862293 bps in 2024, its largest moves.
• Year by year, EBT Margin stood at 6074.86% in 2022, then slumped by 147 bps to 15025.0% in 2023, then jumped by 95 bps to 821.88% in 2024, then jumped by 109 bps to 70.13% in 2025.
• Per Business Quant data, the three most recent EBT Margin figures were 70.13% in Q1 2025, 821.88% in Q4 2024, and 3948.67% in Q3 2024.